AxoSim logo — Building human brains in the lab at scale to heal memory, mo...

AxoSim

Building human brains in the lab at scale to heal memory, movement, and pain disorders.

Founded 2014 United States New Orleans, United States 20 employees Series Unknown Total: $10.05M Biopharma, Biotechnology +1

General Information

Company Name AxoSim
Founded Year 2014
Location United States New Orleans, United States +1
Employees 20
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Series Unknown
Social

Get notified when AxoSim moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AxoSim

AxoSim, with the slogan "Human Data, Faster," is a biopharma company founded in 2014 and headquartered in the United States. The company offers proprietary drug discovery platforms such as NerveSim®, BrainSim®, and microBrain™, which provide clinically-relevant data to select better lead candidates with phenotypically accurate assays. These platforms have applications in peripheral neuropathy, neuropathic pain, disease modeling (such as ALS, MS, and CMT), and neurotoxicology, enabling advancements in human neuroscience. AxoSim recently secured a $6.06M Venture Round investment on 10 June 2021. The company collaborates with biopharma companies to facilitate breakthroughs in devastating neurological diseases and disorders, making it an intriguing prospect for venture capital firms seeking opportunities in the biopharma and biotechnology sectors. For potential investors interested in learning more, they can reach out to AxoSim via email at [email protected].

Taxonomy: Drug Development, Preclinical Testing, Neurotoxicity, Neuroefficacy, 3D Cell Assays, Neurodegenerative Disease Models, Myelination Models, Nerve-on-a-Chip, Organ-on-a-Chip, Peripheral Neuropathy, Toxicology, Neuroscience, Organoids

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 10 Jun 2021
Series A •••••• 1
Investor
28 May 2021
Private Equity Round •••••• 2
Investor Investor
05 Nov 2020
Seed Round •••••• 1
Investor
01 Jun 2019
Venture Round •••••• 1
Investor
07 Mar 2019

View All 11 Funding Rounds

AxoSim Alternatives & Competitors

AxoSim vs

EXPERTS IN 4D TISSUE MODELS

11 employees
Biotechnology, Life Sciences
AxoSim vs
Qureator
Qureator United States

Create to Cure

Series A
22 employees
Biotechnology, Life Sciences
AxoSim vs
Axol Bioscience Ltd.
Axol Bioscience Ltd. United Kingdom

Better Human Disease Models

Series Unknown
49 employees
Biopharma, Biotechnology

FAQ About AxoSim

Building human brains in the lab at scale to heal memory, movement, and pain disorders.
AxoSim was founded in 2014.
AxoSim is headquartered in New Orleans, United States.
AxoSim operates in the following industries: Biopharma, Biotechnology, Life Sciences.
AxoSim has approximately 20 employees.
AxoSim has completed 11 funding rounds, raising a total of $10.05M. The latest funding stage is Series Unknown.
Top alternatives and competitors to AxoSim include REVIVO BioSystems, Qureator , Axol Bioscience Ltd., Emulate, Inc., MIMETAS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AxoSim and REVIVO BioSystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AxoSim and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy